Search Header Logo
Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine

Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine

Assessment

Interactive Video

Health Sciences, Biology

University

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

Pfizer is seeking emergency use authorization for its COVID-19 vaccine, which is reported to be 95% effective. Moderna's vaccine shows similar efficacy. The US has a contract to purchase millions of Pfizer doses, and once approved, the vaccine will be distributed free of charge.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What percentage effectiveness does the first COVID-19 vaccine claim to have?

90%

85%

95%

99%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which company is associated with the first vaccine mentioned in the transcript?

AstraZeneca

Pfizer

Moderna

Johnson & Johnson

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which company developed a second vaccine showing similar results to the first?

Johnson & Johnson

Moderna

AstraZeneca

Novavax

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the US planning to do with the Pfizer-BioNTech vaccine doses?

Sell them to other countries

Use them for research

Distribute them for free

Store them for future use

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Once approved, how will the vaccine shots be provided to the public?

At a discounted price

Free of charge

Only to healthcare workers

Through private clinics only

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?